Loading...
•
Jun 30, 2024
Hims & Hers Q2 2024 Earnings Report
Hims & Hers reported an increase in revenue and subscribers, achieving profitability and raising full-year guidance.
Key Takeaways
Hims & Hers Health, Inc. reported a 52% year-over-year revenue increase to $315.6 million in Q2 2024. The company achieved a net income of $13.3 million and grew its subscriber base to 1.9 million, up 43% year-over-year. Hims & Hers also raised its full year 2024 revenue guidance to $1.37 billion to $1.40 billion and Adjusted EBITDA guidance to $140 million to $155 million.
Revenue increased by 52% year-over-year, reaching $315.6 million in Q2 2024.
Net income was $13.3 million compared to a net loss of $(7.2) million in Q2 2023.
Subscribers grew to 1.9 million, a 43% increase year-over-year.
The company raised its full year revenue guidance to a range of $1.37 billion to $1.40 billion and Adjusted EBITDA guidance to a range of $140 million to $155 million.
Revenue by Segment
Forward Guidance
Hims & Hers provided guidance for Q3 2024 and full year 2024.
Positive Outlook
- Revenue of $375 million to $380 million is expected for Q3 2024.
- Adjusted EBITDA of $35 million to $40 million is expected for Q3 2024.
- Adjusted EBITDA margin of 9% to 11% is expected for Q3 2024.
- Revenue of $1.37 billion to $1.40 billion is expected for the full year 2024.
- Adjusted EBITDA of $140 million to $155 million is expected for the full year 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...